Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children

PLoS Neglected Tropical Diseases

Volumn 10, Issue 11, 2016, Pages

  Uddin, Muhammad Ikhtear ^a   Islam, Shahidul ^a   Nishat, Naoshin S ^a   Hossain, Motaher ^a   Rafique, Tanzeem Ahmed ^a   Rashu, Rasheduzzaman ^a   Hoq, Mohammad Rubel ^a   Zhang, Yue ^b   Saha, Amit ^a   Harris, Jason B ^c,d   Calderwood, Stephen B ^c,d   Bhuiyan, Taufiqur Rahman ^a   Ryan, Edward T ^c,d   Leung, Daniel T ^a,b   Qadri, Firdausi ^a  

^a Mucosal Immunology and Vaccinology Laboratory   (Bangladesh)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; CD14 ANTIGEN; CHOLERA VACCINE; FATTY ACID BINDING PROTEIN 2; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; MYELOPEROXIDASE; RETINOL BINDING PROTEIN; BACTERIUM ANTIBODY; CD4 ANTIGEN; CYTOKINE; IL10 PROTEIN, HUMAN; IMMUNOGLOBULIN G; INACTIVATED VACCINE; PEROXIDASE; RECOMBINANT PROTEIN; SOLUBLE CD4 ANTIGEN; TRACE ELEMENT;

ADOLESCENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BANGLADESH; BLOOD ANALYSIS; CHILD; ENTEROPATHY; ENVIRONMENTAL ENTEROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; MALE; MEMORY T LYMPHOCYTE; NUTRITIONAL STATUS; PRESCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION; VACCINATION; B LYMPHOCYTE; BLOOD; CHEMISTRY; CHOLERA; FECES; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INTESTINAL DISEASES; METABOLISM; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; VIBRIO CHOLERAE O1;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIGENS, CD4; B-LYMPHOCYTES; BANGLADESH; BIOMARKERS; CHILD; CHILD, PRESCHOOL; CHOLERA; CHOLERA VACCINES; CYTOKINES; FECES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; INTESTINAL DISEASES; MALE; MICRONUTRIENTS; PEROXIDASE; RECOMBINANT PROTEINS; VACCINES, INACTIVATED; VIBRIO CHOLERAE O1;

EID: 85007370278     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0005039     Document Type: Article

References (42)

1. Sinclair D, Abba K, Zaman K, Qadri F, Graves PM, (2011) Oral vaccines for preventing cholera. Cochrane Database Syst Rev: CD008603. doi: 10.1002/14651858.CD008603.pub221412922
2. Levine MM, (2010) Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol8: 129. doi: 10.1186/1741-7007-8-12920920375
3. Grassly NC, Jafari H, Bahl S, Sethi R, Deshpande JM, et al. (2012) Waning intestinal immunity after vaccination with oral poliovirus vaccines in India. J Infect Dis205: 1554–1561. doi: 10.1093/infdis/jis24122448007
4. John TJ, (1976) Antibody response of infants in tropics to five doses of oral polio vaccine. Br Med J1: 812. doi: 10.1136/bmj.1.6013.8121260345
5. Jones KD, Hunten-Kirsch B, Laving AM, Munyi CW, Ngari M, et al. (2014) Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial. BMC Med12: 133. doi: 10.1186/s12916-014-0133-225189855
6. Korpe PS, Petri WA, Jr. (2012) Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol Med18: 328–336. doi: 10.1016/j.molmed.2012.04.00722633998
7. Kosek M, Haque R, Lima A, Babji S, Shrestha S, et al. (2013) Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg88: 390–396. doi: 10.4269/ajtmh.2012.12-054923185075
8. Keusch GT, Denno DM, Black RE, Duggan C, Guerrant RL, et al. (2014) Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. Clin Infect Dis59Suppl 4: S207–212. doi: 10.1093/cid/ciu48525305288
9. Mondal D, Minak J, Alam M, Liu Y, Dai J, et al. (2012) Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin Infect Dis54: 185–192. doi: 10.1093/cid/cir80722109945
10. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB, (2012) Cholera. Lancet379: 2466–2476. doi: 10.1016/S0140-6736(12)60436-X22748592
11. Deen JL, von Seidlein L, Sur D, Agtini M, Lucas ME, et al. (2008) The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis2: e173. doi: 10.1371/journal.pntd.000017318299707
12. Arifuzzaman M, Rashu R, Leung DT, Hosen MI, Bhuiyan TR, et al. (2012) Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clin Vaccine Immunol19: 1304–1311. doi: 10.1128/CVI.00196-1222739692
13. (2010) Cholera vaccines: WHO position paper. Wkly Epidemiol Rec85: 117–128. 20349546
14. Harris AM, Bhuiyan MS, Chowdhury F, Khan AI, Hossain A, et al. (2009) Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun77: 3850–3856. doi: 10.1128/IAI.00369-0919528207
15. Jayasekera CR, Harris JB, Bhuiyan S, Chowdhury F, Khan AI, et al. (2008) Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J Infect Dis198: 1055–1061. doi: 10.1086/59150018729782
16. Xu P, Alam MM, Kalsy A, Charles RC, Calderwood SB, et al. (2011) Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines. Bioconjug Chem22: 2179–2185. doi: 10.1021/bc200198421899371
17. Uddin T, Aktar A, Xu P, Johnson RA, Rahman MA, et al. (2014) Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. Am J Trop Med Hyg90: 873–881. doi: 10.4269/ajtmh.13-049824686738
18. Qadri F, Ahmed F, Karim MM, Wenneras C, Begum YA, et al. (1999) Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera. Clin Diagn Lab Immunol6: 812–818. 10548569
19. Leung DT, Rahman MA, Mohasin M, Patel SM, Aktar A, et al. (2012) Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol19: 690–698. doi: 10.1128/CVI.05615-1122441386
20. Campbell DI, Murch SH, Elia M, Sullivan PB, Sanyang MS, et al. (2003) Chronic T cell-mediated enteropathy in rural west African children: relationship with nutritional status and small bowel function. Pediatr Res54: 306–311. doi: 10.1203/01.PDR.0000076666.16021.5E12788978
21. Wolf AA, Jobling MG, Saslowsky DE, Kern E, Drake KR, et al. (2008) Attenuated endocytosis and toxicity of a mutant cholera toxin with decreased ability to cluster ganglioside GM1 molecules. Infect Immun76: 1476–1484. doi: 10.1128/IAI.01286-0718212085
22. Weil AA, Arifuzzaman M, Bhuiyan TR, LaRocque RC, Harris AM, et al. (2009) Memory T-cell responses to Vibrio cholerae O1 infection. Infect Immun77: 5090–5096. doi: 10.1128/IAI.00793-0919703973
23. Erlandson KM, Allshouse AA, Jankowski CM, Lee EJ, Rufner KM, et al. (2013) Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis208: 249–259. doi: 10.1093/infdis/jit14723559466
24. Tibshirani R, (1997) The lasso method for variable selection in the Cox model. Stat Med16: 385–395. 9044528
25. Glass RI, Parashar U, Patel M, Gentsch J, Jiang B, (2014) Rotavirus vaccines: successes and challenges. J Infect68Suppl 1: S9–18. doi: 10.1016/j.jinf.2013.09.01024156947
26. Parker EP, Kampmann B, Kang G, Grassly NC, (2014) Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis. J Infect Dis210: 853–864. doi: 10.1093/infdis/jiu18224688069
27. Lin A, Arnold BF, Afreen S, Goto R, Huda TM, et al. (2013) Household environmental conditions are associated with enteropathy and impaired growth in rural Bangladesh. Am J Trop Med Hyg89: 130–137. doi: 10.4269/ajtmh.12-062923629931
28. Asmuth DM, Ma ZM, Albanese A, Sandler NG, Devaraj S, et al. (2013) Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy. AIDS27: 2207–2217. doi: 10.1097/QAD.0b013e328362e54c23660579
29. Gajda AM, Storch J, (2014) Enterocyte fatty acid-binding proteins (FABPs): Different functions of liver and intestinal FABPs in the intestine. Prostaglandins Leukot Essent Fatty Acids. doi: 10.1016/j.plefa.2014.10.00125458898
30. Pelsers MM, (2008) Fatty acid-binding protein as marker for renal injury. Scand J Clin Lab Invest Suppl241: 73–77. doi: 10.1080/0036551080215013318569970
31. Adriaanse MP, Tack GJ, Passos VL, Damoiseaux JG, Schreurs MW, et al. (2013) Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther37: 482–490. doi: 10.1111/apt.1219423289539
32. Glatz JF, van der Vusse GJ, (1996) Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res35: 243–282. doi: 10.1016/S0163-7827(96)00006-99082452
33. Arndt MB, Richardson BA, Ahmed T, Mahfuz M, Haque R, et al. (2016) Fecal Markers of Environmental Enteropathy and Subsequent Growth in Bangladeshi Children. Am J Trop Med Hyg. doi: 10.4269/ajtmh.16-009827352872
34. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC, (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science249: 1431–1433. doi: 10.1126/science.16983111698311
35. Tapping RI, Tobias PS, (2000) Soluble CD14-mediated cellular responses to lipopolysaccharide. Chem Immunol74: 108–121. doi: 10.1159/00005875110608084
36. Ulevitch RJ, Tobias PS, (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol13: 437–457. doi: 10.1146/annurev.iy.13.040195.0022537542010
37. Funda DP, Tuckova L, Farre MA, Iwase T, Moro I, et al. (2001) CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited. Infect Immun69: 3772–3781. doi: 10.1128/IAI.69.6.3772-3781.200111349042
38. Naylor C, (2015) Enviromental enteropathy, Oral Vaccine Failure and Growth Faltering in Children in Bangladesh. EBioMedicine. doi: 10.1016/j.ebiom.2015.09.03626870801
39. Crossley JR, Elliott RB, (1977) Simple method for diagnosing protein-losing enteropathies. Br Med J1: 428–429. doi: 10.1136/bmj.1.6058.428-a300037
40. Lunn PG, Northrop-Clewes CA, Downes RM, (1991) Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet338: 907–910. doi: 10.1016/0140-6736(91)91772-M1681266
41. Black RE, Allen LH, Bhutta ZA, Caulfield LE, de Onis M, et al. (2008) Maternal and child undernutrition: global and regional exposures and health consequences. Lancet371: 243–260. doi: 10.1016/S0140-6736(07)61690-018207566
42. Huda MN, Lewis Z, Kalanetra KM, Rashid M, Ahmad SM, et al. (2014) Stool microbiota and vaccine responses of infants. Pediatrics134: e362–372. doi: 10.1542/peds.2013-393725002669